CamStent

Each day, thousands of people suffer from heart attacks caused by underlying coronary artery disease. The condition can be corrected by angioplasty, followed by wire-mesh stent to hold the artery open, but protein deposition can occlude the stent. Drug-eluting stents attack the deposits, but do not directly address the underlying attachment process.

We propose to create a novel 'non-stick stent, coated with a non-toxic susbstance that is both hydro- and oleo-phobic. We require £1.5m seed funding to reach Phase 1 clinical trial where we can partner with a device manufacturer to capture 15% of this US$15bn market within five years.